Gaucher Disease-Induced Pluripotent Stem Cells Display Decreased Erythroid Potential and Aberrant Myelopoiesis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gaucher Disease-Induced Pluripotent Stem Cells Display Decreased Erythroid Potential and Aberrant Myelopoiesis
Authors
Keywords
-
Journal
Stem Cells Translational Medicine
Volume 4, Issue 8, Pages 878-886
Publisher
Wiley
Online
2015-06-11
DOI
10.5966/sctm.2014-0213
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gaucher disease: haematological presentations and complications
- (2014) Alison S. Thomas et al. BRITISH JOURNAL OF HAEMATOLOGY
- Induced pluripotent stem cell-derived myeloid phagocytes: disease modeling and therapeutic applications
- (2014) Helen S. Goodridge DRUG DISCOVERY TODAY
- Gaucher iPSC-Derived Macrophages Produce Elevated Levels of Inflammatory Mediators and Serve as a New Platform for Therapeutic Development
- (2014) Leelamma M. Panicker et al. STEM CELLS
- Reprogrammed Cells for Disease Modeling and Regenerative Medicine
- (2013) Anne B.C. Cherry et al. Annual Review of Medicine
- Hematopoietic specification from human pluripotent stem cells: current advances and challenges toward de novo generation of hematopoietic stem cells
- (2013) I. I. Slukvin BLOOD
- B cell lymphoma and myeloma in murine Gaucher's disease
- (2013) EV Pavlova et al. JOURNAL OF PATHOLOGY
- Abnormal properties of red blood cells suggest a role in the pathophysiology of Gaucher disease
- (2012) M. Franco et al. BLOOD
- Reprogramming Cellular Identity for Regenerative Medicine
- (2012) Anne B.C. Cherry et al. CELL
- Efficient and simultaneous generation of hematopoietic and vascular progenitors from human induced pluripotent stem cells
- (2012) Tea Soon Park et al. CYTOMETRY PART A
- Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease
- (2012) L. M. Panicker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD71 (Transferrin Receptor)
- (2010) Derek K. Marsee et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- A cytometric study of the red blood cells in Gaucher disease reveals their abnormal shape that may be involved in increased erythrophagocytosis
- (2010) Daniela Bratosin et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- The majority of the in vitro erythroid expansion potential resides in CD34- cells, outweighing the contribution of CD34+ cells and significantly increasing the erythroblast yield from peripheral blood samples
- (2010) E. van den Akker et al. HAEMATOLOGICA
- Characterization of human embryonic stem cell-derived hematopoietic progenitor phenotype
- (2010) Hai-Yang Zhou et al. IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
- Common and Uncommon Pathogenic Cascades in Lysosomal Storage Diseases
- (2010) Einat B. Vitner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Gaucher disease with foamy transformed macrophages and erythrophagocytic activity
- (2010) Maciej Machaczka et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage
- (2010) P. K. Mistry et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis
- (2009) K. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells
- (2008) E. T. Zambidis et al. BLOOD
- Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)
- (2008) Kathleen S. Hruska et al. HUMAN MUTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More